{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:07:05Z","timestamp":1715980025841},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T00:00:00Z","timestamp":1436054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12985-015-0333-1","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T00:05:14Z","timestamp":1435968314000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Standardization of the methods and reference materials used to assess virus content in varicella vaccines"],"prefix":"10.1186","volume":"12","author":[{"given":"JiYoung","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Jung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naery","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do-Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heui-Seong","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seokkee","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hak","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyejoo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,5]]},"reference":[{"key":"333_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/01.inf.0000160947.89942.30","volume":"24","author":"R Sheffer","year":"2005","unstructured":"Sheffer R, Segal D, Rahamani S, Dalal I, Linhart Y, Stein M. Effectiveness of the Oka\/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J. 2005;24:434\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"333_CR2","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.4161\/hv.25228","volume":"9","author":"B Unim","year":"2013","unstructured":"Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, et al. Economic evaluation of varicella vaccination (Results of a systematic review). Hum Vaccin Immunother. 2013;9:1932\u201342.","journal-title":"Hum Vaccin Immunother"},{"key":"333_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1056\/NEJM200103293441302","volume":"344","author":"M V\u00e1zquez","year":"2001","unstructured":"V\u00e1zquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med. 2001;344:955\u201360.","journal-title":"N Engl J Med"},{"key":"333_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00128072-200103040-00005","volume":"3","author":"M Takahashi","year":"2001","unstructured":"Takahashi M. 25 years\u2019 experience with the Biken Oka strain varicella vaccine: a clinical review. Paediatr Drugs. 2001;3:285\u201392.","journal-title":"Paediatr Drugs"},{"key":"333_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/rmv.1789","volume":"24","author":"M Quinlivan","year":"2014","unstructured":"Quinlivan M, Breuer J. Clinical and molecular aspects of the live attenuated Oka varicella vaccine. Rev Med Virol. 2014;24:254\u201373.","journal-title":"Rev Med Virol"},{"key":"333_CR6","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1086\/522163","volume":"197","author":"C Sadzot-Delvaux","year":"2008","unstructured":"Sadzot-Delvaux C, Rentier B, Wutzler P, Asano Y, Suga S, Yoshikawa T, et al. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis. 2008;197:S185\u2013190.","journal-title":"J Infect Dis"},{"key":"333_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1128\/CVI.00645-13","volume":"21","author":"SH Oh","year":"2014","unstructured":"Oh SH, Choi EH, Shin SH, Kim YK, Chang JK, Choi KM, et al. Varicella and varicella vaccination in South Korea. Clin Vaccine Immunol. 2014;21:762\u20138.","journal-title":"Clin Vaccine Immunol"},{"key":"333_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0166-0934(97)00063-3","volume":"66","author":"H Heider","year":"1997","unstructured":"Heider H, Schroeder C. Focus luminescence assay: macroscopically visualized foci of human cytomegalovirus and varicella zoster virus infection. J Vriol Methods. 1997;66:311\u20136.","journal-title":"J Vriol Methods"},{"key":"333_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0166-0934(90)90100-T","volume":"27","author":"DL Krah","year":"1990","unstructured":"Krah DL, Schofield TL, Provost PL. Enhancement of varicella-zoster virus plaquing efficiency with an agarose overlay medium. J Virol Methods. 1990;27:319\u201326.","journal-title":"J Virol Methods"},{"key":"333_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/1743-422X-8-547","volume":"8","author":"JI Kim","year":"2011","unstructured":"Kim JI, Jung GS, Kim YY, Ji GY, Kim HS, Wang WD, et al. Sequencing and characterization of Varicella-Zoster virus vaccine strain Suduvax. Virol J. 2011;8:547.","journal-title":"Virol J"},{"key":"333_CR11","first-page":"572","volume":"25","author":"YH Kim","year":"2010","unstructured":"Kim YH, Kim DK, Sohn YW, Han ER, Lim JM, Kim KH, et al. Manufacturing and establishment of the 2nd national standard for varicella vaccine. Korean Soci Biotech Bioengineer Journal. 2010;25:572\u20136.","journal-title":"Korean Soci Biotech Bioengineer Journal"},{"key":"333_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/rmv.502","volume":"16","author":"M Quinlivan","year":"2006","unstructured":"Quinlivan M, Breuer J. Molecular studies of varicella zoster virus. Rev Med Virol. 2006;16:225\u201350.","journal-title":"Rev Med Virol"},{"key":"333_CR13","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","volume":"32","author":"R Chlibek","year":"2014","unstructured":"Chlibek R, Smetana J, Pauksens K, Rombo L, Van den Hoek JA, Richardus JH, et al. Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study. Vaccine. 2014;32:1745\u201353.","journal-title":"Vaccine"},{"key":"333_CR14","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/infdis\/jit344","volume":"208","author":"KM Mullane","year":"2013","unstructured":"Mullane KM, Winston DJ, Wertheim MS, Betts RF, Porstz DM, Camacho LH, et al. Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults. J Infect Dis. 2013;208:1375\u201385.","journal-title":"J Infect Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0333-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-015-0333-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0333-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0333-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T16:50:34Z","timestamp":1630601434000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-015-0333-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,5]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1186\/s12985-015-0333-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,5]]},"assertion":[{"value":"3 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"101"}}